MARKET

IBB

IBB

iShares Biotechnology ETF
NASDAQ
169.00
+0.23
+0.14%
After Hours: 169.00 0 0.00% 19:57 01/02 EST
OPEN
169.65
PREV CLOSE
168.77
HIGH
169.77
LOW
167.47
VOLUME
1.93M
TURNOVER
--
52 WEEK HIGH
174.21
52 WEEK LOW
107.25
TOTAL ASSET
8.27B
YTD YIELD
27.54%
1D
5D
1M
3M
1Y
5Y
1D
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge
Seeking Alpha · 12/30/2025 13:57
Weekly Report: what happened at IBB last week (1222-1226)?
Weekly Report · 12/29/2025 10:10
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
NASDAQ · 12/26/2025 11:20
Beyond S&P 500: KKR Flags Asia, Biotech, Infrastructure As Next 'High-Grade' Trades For 2026
Benzinga · 12/24/2025 08:12
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus
Benzinga · 12/23/2025 19:04
Why Is Trinity Biotech Stock Soaring Tuesday?
Benzinga · 12/23/2025 14:59
Weekly Report: what happened at IBB last week (1215-1219)?
Weekly Report · 12/22/2025 10:10
Key Takeaways From Equity Earnings Calls: Q3 2025
Seeking Alpha · 12/19/2025 08:10
More
Profile
Fund Name
iShares Biotechnology ETF
Inception Date
2001-02-05
Benchmark
ICE Biotechnology TR USD
Advisor Company
iShares
Custodian
JPMorgan Chase Bank, N.A.
Manager
Greg Savage, Jennifer Hsui, Amy Whitelaw, Paul Whitehead, Peter Sietsema, Matt Waldron, Steven White